HMO mergers and Medicare: the antitrust issues

R Feldman1, R S Given

  • 1University of Minnesota School of Public Health, Minneapolis 55455-0392, USA.

Health Economics
|July 4, 1998
PubMed

Insights

Mergers of large Medicare Health Maintenance Organizations (HMOs) warrant antitrust scrutiny due to market entry barriers. The PacifiCare and FHP merger exemplifies potential antitrust concerns in this growing sector.

Area of Science:

  • Health Economics
  • Antitrust Law
  • Market Regulation

Background:

  • The Medicare Health Maintenance Organization (HMO) market is experiencing rapid growth.
  • Significant barriers to entry exist within this market.
  • Consolidation through mergers is becoming prevalent.

Purpose of the Study:

  • To present a theoretical framework for predicting the effects of mergers in the Medicare HMO market.
  • To identify Medicare HMO mergers that should be targeted for antitrust investigation.
  • To illustrate potential antitrust issues using a specific merger case.

Main Methods:

  • Development of a theoretical framework for merger analysis.
  • Application of the framework to the Medicare HMO market.
  • Case study analysis of the PacifiCare and FHP merger.

Main Results:

  • The theoretical framework predicts significant market effects from large Medicare HMO mergers.
  • Mergers involving large Medicare HMOs present substantial antitrust concerns.
  • The PacifiCare/FHP merger highlights specific antitrust issues related to market concentration and barriers to entry.

Conclusions:

  • Mergers of large Medicare HMOs require antitrust investigation due to inherent market entry barriers.
  • The theoretical framework provides a basis for evaluating future Medicare HMO mergers.
  • Antitrust vigilance is crucial to maintain competition and protect beneficiaries in the evolving Medicare HMO landscape.

Related Concept Videos

Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Integrated Healthcare System01:20

Integrated Healthcare System

An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
Healthcare Agencies II01:17

Healthcare Agencies II

There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.